ANCA Associated Vasculitis (Anti-Neutrophil Cytoplasmic Antibody) - Causes, Pathophysiology, Types
Current issues in ANCA associated vasculitis
ANCA Associated Vasculitides: Clinical Aspects
KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment
Mechanism of Disease: ANCA-associated vasculitis (AAV)
Opportunities to Further Care in ANCA-Associated Vasculitis: GPA and MPA
ANCA Associated Vasculitides: Diagnosis & Treatment
Diagnosing Severe Active ANCA-Associated Vasculitis: Importance of Clinical Assessment in GPA & MPA
Understanding ANCA-Associated Vasculitis
Understanding Challenges in Traditional Care of ANCA-Associated Vasculitis: GPA and MPA
Anti Neutrophilic Cytoplasmic Antibodies (ANCA)
ANCA-Associated Vasculitis Guidelines: Dr. Mike Putman
Update on ANCA-Associated Vasculitis
ANCA-associated GN: the Known and the Unknowns with Dr Andreas Kronbichler
Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis with Dr. Peter Merkel
ANCA Associated Vasculitis
Avacopan - C5a Receptor Inhibitor - in ANCA-Associated Vasculitis: Dr. Arthur Kavanaugh
Vision Loss with ANCA-Associated Vasculitis
ANCA-associated Vasculitis: Update Therapy 2023 - Prof. Dr. Alexandre Karras (Paris, France)
Goals of Care and Traditional Approaches to ANCA-Associated Vasculitis: GPA and MPA
